EKF Diagnostics (LON:EKF) Shares Down 7% – Time to Sell?

EKF Diagnostics Holdings plc (LON:EKF) shares were down 7% during trading on Saturday . The stock traded as low as GBX 23.60 ($0.31) and last traded at GBX 26 ($0.35). Approximately 2,281,890 shares traded hands during mid-day trading, an increase of 404% from the average daily volume of 453,091 shares. The stock had previously closed at GBX 27.95 ($0.37).

EKF Diagnostics Trading Down 7.0%

The business has a 50 day moving average of GBX 29.18 and a two-hundred day moving average of GBX 26.59. The firm has a market capitalization of £116.76 million, a price-to-earnings ratio of 19.26 and a beta of 0.57. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60.

EKF Diagnostics (LON:EKF) last announced its quarterly earnings data on Tuesday, September 16th. The company reported GBX 0.43 EPS for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. Equities analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.